Edgestream Partners, L.P. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Edgestream Partners, L.P. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$335,309
-75.6%
477,036
-21.6%
0.04%
-76.1%
Q4 2022$1,376,003
-58.9%
608,851
-41.9%
0.16%
-40.2%
Q3 2022$3,352,000
-17.3%
1,047,636
-1.8%
0.26%
-19.1%
Q2 2022$4,054,000
+20.6%
1,066,788
+71.0%
0.32%
+19.4%
Q1 2022$3,362,000
+521.4%
623,707
+1457.7%
0.27%
+688.2%
Q4 2021$541,00040,0400.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders